Mutant recombinant hemoglobins containing heme pocket mutations

Details Mutant recombinant hemoglobins containing heme pocket mutations Mutant recombinant hemoglobins containing heme pocket mutations

1995-01-30

2000-02-08

Carlson, Karen C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530385, C07K 14805

Patent

active

060228490

ABSTRACT:
This invention relates to recombinant hemoglobins containing mutations in or near the heme pocket of the hemoglobin molecule. This invention particularly relates to recombinant hemoglobins that have altered geometry or polarity around the distal portion of the heme pocket.

REFERENCES:
patent: Re34271 (1993-06-01), Walder
patent: 4826811 (1989-05-01), Sehgal et al.
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5084558 (1992-01-01), Rausch
patent: 5194590 (1993-03-01), Sehgal et al.
patent: 5239061 (1993-08-01), Fronticelli et al.
Ogata et al./Hemoglobin Sendagi (.beta.42 PHE.fwdarw.VAL): A New Unstable Hemoglobin Variant Having an Amino Acid Substitution at CDI of the .beta.-Chain/Hemoglobin, 10(5): 469-481 (1986).
Wajcman et al/Two New Hemoglobin Variants with Deletion Hemoglobin Tours . . . Biochimica et Biophysica Acta, 295: 495-504 (1973).
Nagai, K. et al.; "Generation of .beta.-Globin by Sequence-Specific Proteolysis of a Hybrid Protein Produced in Escherichia coli"; Nature 309, 810-812 (1984).
Nagai, K. et al.,; "Oxygen Binding Properties of Human Mutant Hemoglobins Synthesized in Escherichia coli "; Proc. Natl. Acad. Sci. USA 82, 7252-7255 (1985).
Luisi et al.; "Crystallographic Analysis of Mutant Human Haemoglobins made in Escherichia coli"; Nature 320, 555-556 (1986).
Springer et al.; "High-level Expression of Sperm Whale Myoglobin in Escherichia coli "; Proc. Natl. Acad. Sci. USA 84, 8961-8965 (Dec. 1987).
Nagai et al.; "Synthesis and Sequence-Specific Proteolysis of Hybrid Proteins produced in Escherichia coli"; Methods Enzymol. 153, 461-481 (1987).
Nagai et al.; "Distal Residues in the Oxygen Binding Site of Haemoglobin Studied by Protein Engineering"; Nature 329, 858-860 (1987).
Olson et al.; "The Role of the Distal Histidine in Myoglobin and Haemoglobin"; Nature 336, 265-266 (1988).
Matthews et al.; "The Effects of E7 and E11 Mutations on the Kinetics of Ligand Binding to R State Human Hemoglobin*"; J. Biol. Chem. 264, 16573-16583 (1989).
Egeberg et al.; "The Role of Val.sup.68 (E11) in Ligand Binding to Sperm Whale Myoglobin"; J. Biol. Chem. 265, 11788-11795 (1990).
Rohlfs et al.; "The Effects of Amino Acid Substitution at Position E7 (Residue 64) on the Kinetics of Ligand Binding to Sperm Whale Myoglobin*"; J. Biol. Chem. 265, 3168-3176 (1990).
Tame et al.; "Functional Role of the Distal Valine (E11) Residue of .alpha. Subunits in Human Haemoglobin"; J. Mol. Biol. 218, 761-767 (1991).
Doherty et al., Rate of Reaction with Nitric Oxide Determines the Hypertensive Effect of Cell-Free Hemoglobin, Nature Biotechnology, vol. 16, Jul. 1998, pp. 672-676.
Weickert et al., Turnover of Recombinant Human Hemoglobin in Escherichia coli Occurs Rapidly for Insoluble and Slowly for Soluble Globin, Archives of Biochemistry and Biophysics, vol. 348, No. 2, Dec. 15, 1997, pp. 337-346.
Eich et al., Mechanism of NO-Induced Oxidation of Myoglobin and Hemoblobin, 1996 American Chemical Society, Biochemistry 1996, vol. 35, No. 22, pp. 6976-6983.
Shen et al., Production of Unmodified Human Adult Hemoglobin Escherichia coli, Proc. Natl. Acad. Sci., vol. 90, Sep. 1993, pp. 8108-8112.
Dumoulin et al., Two Mutations in Recombinant Hb .beta. F41(C7) Y, K82 (EF6) D Show Additive Effects in Decreasing Oxygen Affinity Protein Science 1996, pp. 114-120.
Pechik et al., Crystallographic, Molecular Modeling, and Biophysical Characterization of the Valine.beta.67 (E11) Threonine Variant of Hemoglobin, Biochemistry 1996, vol. 35, No. 6, pp. 1935-1945.
Kiger et al., Recombinant [Phe.beta.63] Hemoglobin Shows Rapid Oxidation of the .beta. Chains and Low-Affinity, Non-Cooperative Oxygen Binding to the .alpha. Subunits, Eur. J. Biochem. 243, Feb. 1997, pp. 365-373.
Hoffman et al., Expression of Fully Functional Tetrameric Human Hemoglobin in Escherichia coli, Proc. Natl. Acad. Sci., vol. 87, Nov. 1990, pp. 8521-8525.
Fronticelli & Shoaee/Modulation of Nitric Oxide Affinity by Amino Acid Resides in the Pocket of the B-Chains/Art. Cells, Blood Subs. & Immobi. Biotech./(1994) 22(5):83.
Militello et al./Dynamic Properties of Some .beta.-Chain Mutant Hemoglobins/Proteins: Structure, Function, and Genetics/(1995) 22:12-19.
Fronticelli et al./Recombinant Human Hemoglobin: Modification of the Polarity of the .beta.-Heme Pocket by a Valine.sup.67 (E11).fwdarw.Threonine Mutation/Biochemistry/(1993) 32:1235-1242.
Anderson 1976 J. Clin. Invest. 58:1107-1109.
Adams 1987 Hemoglobin 11(5): 435-452.
Nagai: et al Oct. 1987, Nature 329:858-860.
Lulsi et al. 1986 Nature 320:555-556.
Winslow, R.M./Hemoglobin-Based Red Cell Substitutes/(1992) Entire Book/The Johns Hopkins Univ. Press/Baltimore.
Snyder, S.H. & Bredt,D.S./Biological Roles of Nitric Oxide/Scientific American/(1992) May 68-77.
Fermi, G. et al./The Crystal Structure of Human Deoxyhaemoglobin at 1-74 a Resolution/ J. Mol. Biol/(1984) 175:159-174.
Looker, D. et al/Expression of Recombinant Human Hemoglobin in Echerichia Coli/ Methods in Enzymology/(1994) 231:364-374.
Matthews, A.J. et al/The Effects of E7 and E11 Mutations on the Kinetics of Ligand Binding to R State Human Hemoglobin/J. of Biol. Chem/(1989) 264(28)16573-16583.
Moncada, S. et al/Nitric Oxide: Physiology, Pathophysiology and Pharmacology/ Pharm. Reviews/(1991) 43(2): 109-142.
Perutz, M.F./Myoglobin and Haemoglobin: Role of Distal Residues in Reactions with Haem Lignads/Trends Biochem. Sci./(1989) 14:42-44.
Rachmilewitz, E.A./Denaturation of the Normal and Abnormal Hemolgobin Molecule/Seminars In Hematology/(1974) 11(4): 441-462.
Reichelt, H. et al/Blood Substitutes Made on the Basis of Perfluoracarbons Inhibit Intracellular Energy Generation/Blood Substitutes and Oxygen Carriers/(1992) 769-772/ T.M. Chang Editor.
Spahn, D.R. et al/Cardiovascular and Coronary Physiology of Acute Isovolemic Hemodilution: A Review of Nonoxygen-Carrying and Oxygen-Carrying Solutions/Anesth Analg/(1994) 78: 1000-1021.
Springer, B.A. et al/Chemical Rev./Mechanisms of Ligand Recognition in Myoglobin/(1994) 94: 699-714.
Vlahakes, G.J. et al/Hemodynamic Effects and Oxygen Transport Properties of a New Blood Substitute in a Model of Massive Blood Replacement/J. Thorac Cardiovasc. Surg/(1990) 100: 379-388.
White, C.T. et al/Toxicity of Human Hemoglobin Solution Infused Into Rabbits/J. Lab Clin Med/(1986) 108: 121-131.
Biro, G.P. et al/Studies on Blood Substitutes Based on Hemoglobin and Perfluorocarbon/ Biomat/. Art. Cells & Immob. Biotech./(1992) 20(2-4): 1013-1020.

Affiliated with

Also associated with

Rating

Mutant recombinant hemoglobins containing heme pocket mutations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutant recombinant hemoglobins containing heme pocket mutations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant recombinant hemoglobins containing heme pocket mutations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1681532